GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (NAS:FLGC) » Definitions » Enterprise Value

Flora Growth (Flora Growth) Enterprise Value : $16.79 Mil (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Flora Growth Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Flora Growth's Enterprise Value is $16.79 Mil. Flora Growth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-48.19 Mil. Therefore, Flora Growth's EV-to-EBIT ratio for today is -0.35.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Flora Growth's Enterprise Value is $16.79 Mil. Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-46.57 Mil. Therefore, Flora Growth's EV-to-EBITDA ratio for today is -0.36.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Flora Growth's Enterprise Value is $16.79 Mil. Flora Growth's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $74.78 Mil. Therefore, Flora Growth's EV-to-Revenue ratio for today is 0.22.


Flora Growth Enterprise Value Historical Data

The historical data trend for Flora Growth's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Enterprise Value Chart

Flora Growth Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
- - 80.12 25.27 11.38

Flora Growth Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.47 17.21 6.68 11.38 22.29

Competitive Comparison of Flora Growth's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flora Growth's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Flora Growth's Enterprise Value falls into.



Flora Growth Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Flora Growth's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Flora Growth's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flora Growth  (NAS:FLGC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Flora Growth's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=16.794/-48.188
=-0.35

Flora Growth's current Enterprise Value is $16.79 Mil.
Flora Growth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-48.19 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Flora Growth's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=16.794/-46.572
=-0.36

Flora Growth's current Enterprise Value is $16.79 Mil.
Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.57 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Flora Growth's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=16.794/74.783
=0.22

Flora Growth's current Enterprise Value is $16.79 Mil.
Flora Growth's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $74.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flora Growth Enterprise Value Related Terms

Thank you for viewing the detailed overview of Flora Growth's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Flora Growth (Flora Growth) Business Description

Traded in Other Exchanges
N/A
Address
3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.
Executives
Thomas Solomon director C/O FLORA GROWTH CORP., 365 BAY STREET; SUITE 800, TORONTO Z4 M5H 2V1
Kevin Taylor director C/O COOL HOLDINGS, INC., 2001 NW 84TH AVENUE, MIAMI FL 33122
Hussein Rakine director, officer: Chief Executive Officer 5258 SW 183RD AVENUE, MIRAMAR FL 33029
Clifford Starke director, officer: President C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Edward Woo director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
John Timothy Leslie director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Marc Mastronardi director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jason Warnock officer: CCO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Annabella Manalo Morgan director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jessie Casner officer: CMO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Dany Vaiman officer: Sr. VP Finance C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Elshad Garayev officer: CFO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Beverley Richardson director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Roa Juan Carlos Gomez director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Luis Merchan director, officer: CEO & Chairman of the Board C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312